A surprising link between innate immunity and nuclear reprogramming is reported by Lee et al.; this discovery may boost the efficiency of stem cell production.
Innate immunity primarily involves germline-encoded receptors that recognize conserved microbial structures, triggering signaling pathways that induce the expression of a wide range of proteins critical for disease resistance. Despite its ubiquity and importance, the link between innate immunity and the induction of pluripotent stem cells uncovered by Lee et al. (2012) in this issue of Cell is far from obvious. They demonstrate that activation of toll-like receptor-3 (TLR3) causes changes in expression of epigenetic modifiers, thereby facilitating nuclear reprogramming in the presence of the transcription factor cocktail consisting of Oct4, Sox2, Klf4, and c-Myc (Figure 1 ). This new approach could optimize the induction of pluripotent stem cells from somatic cells and may provide a whole new means for stem cell production.
Landmark studies by Yamanaka (rewarded with the Nobel Prize for Medicine of Physiology in 2012) and colleagues demonstrated that the expression of four transcription factors, Oct4, Sox2, Klf4, and c-Myc (OSKM), could induce pluripotency in somatic cells such as fibroblasts (Takahashi et al., 2007) . This OSKM protocol was an important breakthrough in stem cell research, but the mechanism was uncertain. Retroviral expression of the proteins led to concerns about integration into the host genome that might dysregulate expression of other important host genes and have deleterious effects, including cellular transformation. The OSKM proteins themselves, when rendered cell permeable, could achieve the same effect, although curiously with much lower efficiency (Cho et al., 2010) . Lee et al. (2012) address this inefficiency by first comparing the ability of retrovirally encoded Sox2 (as a sample OSKM protein) to cell-permeant Sox2 to induce pluripotency. Both were applied to fibroblasts and downstream targets of Sox2, such as Jarid2, as well as markers of nuclear reprogramming, such as Nanog, were measured. Both types of response are enhanced in response to retrovirally encoded Sox2, whereas cell-permeant Sox2 is much less effective. A similar difference is observed with Oct4. The authors hypothesized that an intrinsic feature of viral particles might be responsible for the different efficiencies. They confirm this by demonstrating that the viral vector alone, which does not encode Sox2, when combined with cell-permeant Sox2 could induce similar gene expression changes as that induced by the vector when it encoded Sox2.
Given that certain TLRs sense nucleic acids (usually derived from microbes), the authors wondered if TLR activation might be involved. They examined TLR3 because this is known to sense viral RNA (Alexopoulou et al., 2001 ) and so might sense the retroviral vector. TLR3 signals via the adaptor protein Trif (Yamamoto et al., 2003) , and so the authors knocked down TLR3 or Trif and found inhibition of the induction of pluripotency genes by the retrovirally encoded Oct4. Knockdown of both TLR3 and Trif also blocks the induction of human induced pluripotent stem cells (iPSCs) by retroviral reprogramming in fibroblasts, as assessed morphologically 30 days after transfection. This important result indicates that TLR3 activation can induce human iPSCs by using the approach first described by Yamanaka. The effect of TLR3 activation is also evident with modified messenger RNA (mmRNA)-encoded OSKM. The authors then tested a synthetic TLR3 agonist, poly I:C. This has the same effect as the retroviral particles, which dramatically accelerates the development of iPSCs in fibroblasts exposed to OSKM cell-permeant proteins.
Probing the potential mechanisms, the authors hypothesized that TLR3 activation might lead to epigenetic modification, and found that fibroblasts treated with retrovirally encoded Sox2 or cell-permeant Sox2 in the presence of poly I:C induce H3K4 trimethylation at the Oct4 promoter indicative of an open chromatin state, the Oct4 gene being a target for Sox2. H3K9 methylation of the Oct4 promoter, which is indicative of gene silencing, was decreased. Poly I:C also downregulates expression of histone deacetylase (HDAC) genes, consistent with the opening of chromatin structure, since HDACs via deacetylation of chromatin are associated with a closed chromatin state. Poly I:C also accelerates redistribution of heterochromatin protein 1, a protein that consolidates chromatin repression, consistent with genomewide epigenetic alterations promoted by TLR3. Both NF-kappaB and IRF3, two well-known signals activated by TLR3, are also shown to be involved in the induction of pluripotency in response to TLR3 activation, since knockdown of IRF3 or blockade of NF-kappaB both inhibit this response. Poly I:C also induces changes in expression of a whole host of enzymes involved in chromatin modification, consistent with the mechanism of action of poly I:C being to induce epigenetic changes in the genome to allow OSKM to reprogram gene expression and induce pluripotency. One of these enzymes, H3K79 histone methyltransferase (Dot1L) is suppressed by poly I:C, and the inhibition of this enzyme has previously been shown to be critical for somatic cell reprogramming (Onder et al., 2012) . Importantly, the histone modifications on the Oct4 and Sox2 promoters and the heterochromatin protein 1 redistribution are only seen when poly I:C is coadministered with the cell-permeant proteins, indicating that the reprogramming proteins are needed to direct the epigenetic modifiers to the appropriate promoter sequences.
As the authors themselves therefore state, this study has serendipitously found a role for innate immune signaling in nuclear reprogramming leading to the induction of pluripotent stem cells from somatic cells. TLR3 plays an important role in the recognition of double-stranded RNA from retroviruses and activates a signaling pathway culminating in the induction of a wide range of antiviral proteins (Onder et al., 2012) . Epigenetic modification of chromatin by TLRs has been reported before (Medzhitov and Horng, 2009 ) and is presumably important for the increase in expression of host defense genes during infection. Here, however, this epigenetic response is being deployed to allow for nuclear reprogramming by OSKM in a manner potentially safer than one using retrovirally encoded proteins. It is likely that other innate immune receptors will have a similar effect. Because the adaptor Trif is shown to be involved, it is possible that TLR4, which senses lipopolysaccharides (LPS) from gram negative bacteria and also signals via Trif (Yamamoto et al., 2002) , might be capable of inducing a similar response. Key downstream responses of TLR3 and TLR4 signaling include the type I interferons, and these might also play a role here, in which case other innate receptors that can induce type I interferons, such as the single-stranded RNA sensor RIG-I (Yoneyama et al., 2004) , or DNA sensors, such as IFI16 (Unterholzner et al., 2010) , might also have a function similar to TLR3. These other receptors are therefore worth exploring, and, because they are all proinflammatory, inspired the authors to coin the term ''transflammation'' to describe the potential of these epigenetic modifiers to induce pluripotency.
Whatever emerges, this discovery represents a new beginning in the effort , and c-Myc in combination with TLR3 stimulation with poly I:C induces nuclear reprogramming in fibroblasts, giving rise to induced pluripotent stem cells. The same effect can be achieved by transfection of fibroblasts with a retroviral vector encoding the proteins, the retroviral vector also acting via TLR3. The effect of TLR3 is to activate NF-kappaB and IRF3 via the adaptor Trif. The NF-kappaB pathway leads to chromatin modification, including induction of histone acetyltransferases, histone methyltransferase, decreased expression of HDACs, H3K4 histone methyltransferase, and H3K79 histone methyltransferase. IRF3 might mediate it's effects via type I interferons and Trims, which silence endogenous retroelements. The combination of OSKM and TLR3 activation is needed for increased H3K4 methylation and decreased H3K9 methylation of the promoters for nuclear reprogramming genes regulated by OSKM, as well as HP1 redistribution. The OSKM reprogramming proteins are therefore needed to direct the epigenetic modifiers activated by TLR3 to the appropriate promoter sequences to induce genes involved in nuclear reprogramming and generation of iPSCs.
to develop a safe and effective protocol to create induced pluripotent stem cells. Time will tell if this protocol will have clinical utility in this important area of biomedical research.
